Rockwell Collins will sell Kaiser Optical Systems to Endress+Hauser.
Rockwell Collins announced that it has agreed to sell its subsidiary, Kaiser Optical Systems, a spectrographic instrumentation and applied holographic technology company, to Endress+Hauser, a producer of measurement instrumentation and services for industrial process engineering. Terms of the agreement were not disclosed. The sale is expected to be complete in early fiscal 2014 and is subject to customary closing conditions.
Kaiser Optical Systems, located in Ann Arbor, Michigan, became a Rockwell Collins company in 2000 as part of the company’s purchase of K Systems, the parent company of Kaiser Aerospace and Electronics. Principal products include Raman sensors and instrumentation, advanced holographic components for
spectroscopy, telecommunications, astronomy and ultra-fast sciences, and components for aircraft display systems.
Source: Rockwell Collins
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.